These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15837601

  • 1. Strategies for producing faster acting antidepressants.
    Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F.
    Drug Discov Today; 2005 Apr 15; 10(8):578-85. PubMed ID: 15837601
    [Abstract] [Full Text] [Related]

  • 2. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ.
    Depress Anxiety; 2005 Apr 15; 4(4):153-9. PubMed ID: 9166647
    [Abstract] [Full Text] [Related]

  • 3. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.
    Millan MJ.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):371-84. PubMed ID: 15464046
    [Abstract] [Full Text] [Related]

  • 4. Neuropharmacological basis of combining antidepressants.
    de la Gándara J, Rojo JE, Ros S, Agüera L, de Pedro JM.
    Acta Psychiatr Scand Suppl; 2005 Oct 01; (428):11-3, 36. PubMed ID: 16307615
    [Abstract] [Full Text] [Related]

  • 5. Long-term adaptive changes induced by serotonergic antidepressant drugs.
    Faure C, Mnie-Filali O, Haddjeri N.
    Expert Rev Neurother; 2006 Feb 01; 6(2):235-45. PubMed ID: 16466303
    [Abstract] [Full Text] [Related]

  • 6. New approaches to antidepressant drug discovery: beyond monoamines.
    Berton O, Nestler EJ.
    Nat Rev Neurosci; 2006 Feb 01; 7(2):137-51. PubMed ID: 16429123
    [Abstract] [Full Text] [Related]

  • 7. Antidepressants: current concepts of mode of action.
    Cowen PJ.
    Int Clin Psychopharmacol; 1990 Jul 01; 5 Suppl 3():45-55. PubMed ID: 2172364
    [Abstract] [Full Text] [Related]

  • 8. Models of antidepressant action.
    Berman RM, Charney DS.
    J Clin Psychiatry; 1999 Jul 01; 60 Suppl 14():16-20; discussion 31-5. PubMed ID: 10408421
    [Abstract] [Full Text] [Related]

  • 9. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N.
    Drug News Perspect; 2007 Dec 01; 20(10):613-8. PubMed ID: 18301795
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An ideal trial to test differential onset of antidepressant effect.
    Leon AC, Blier P, Culpepper L, Gorman JM, Hirschfeld RM, Nierenberg AA, Roose SP, Rosenbaum JF, Stahl SM, Trivedi MH.
    J Clin Psychiatry; 2001 Dec 01; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Neurobiological mechanisms of depression and antidepressant therapy].
    Shishkina GT, Dygalo NN.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010 Dec 01; 60(2):138-52. PubMed ID: 20469588
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets.
    Kennedy SH, Young AH, Blier P.
    J Affect Disord; 2011 Aug 01; 132 Suppl 1():S21-8. PubMed ID: 21571374
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.